Pharma & Biotech

Investors in Cellectar Biosciences are bracing for significant volatility as the company approaches two major developments that could dramatically influence...

The equity performance of Gilead Sciences has captured significant market attention, with its shares advancing more than 25% since the...

Sarepta Therapeutics shares advanced 3.6% to $18.72 in the latest trading session, yet this modest gain conceals a deeply fractured...

The leadership team at Redcare Pharmacy is undergoing a significant transition as the company's long-serving Chief Financial Officer announces his...

The telehealth sector, known for its rapid digital innovation, is facing increased regulatory scrutiny. Hims & Hers Health, Inc., a...

Pharmaceutical giant Bristol-Myers Squibb is navigating turbulent waters as it implements an unconventional approach to maintain its market position. With...

The gene editing sector is witnessing remarkable developments as Intellia Therapeutics demonstrates groundbreaking progress with its CRISPR-based therapies. Within a...

Biopharmaceutical company Axsome Therapeutics has moved to resolve significant legal challenges through a proposed $7.75 million settlement agreement. This development...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...

Viking Therapeutics finds itself at a critical investment crossroads, pulled in opposite directions by two powerful market forces. Soaring takeover...